Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

CD263 (TRAIL-R3) Rabbit anti-Human, Polyclonal, Invitrogen™

Rabbit Polyclonal Antibody

Manufacturer:  Invitrogen PA129165

Catalog No. PIPA129165


Add to cart

Description

Description

PA1-29165 detects DcR1 from human samples. PA1-29165 has been successfully used in immunohistochemistry (paraffin tissue) applications. The PA1-29165 immunogen is: Synthetic peptide corresponding to the N-terminal extracellular domain of human DcR1 precursor protein. Positive Control: Placenta

TRAIL-R3 (CD263) is a member of the TNF-receptor superfamily. This receptor contains an extracellular TRAIL-binding domain and a transmembrane domain, but no cytoplasmic death domain. This receptor is not capable of inducing apoptosis, and is thought to function as an antagonistic receptor that protects cells from TRAIL-induced apoptosis. This gene was found to be a p53-regulated DNA damage-inducible gene. The expression of this gene was detected in many normal tissues but not in most cancer cell lines, which may explain the specific sensitivity of cancer cells to the apoptosis-inducing activity of TRAIL.
Specifications

Specifications

CD263 (TRAIL-R3)
Polyclonal
Unconjugated
TNFRSF10C
Liquid
TNFRSF10C
Synthetic peptide corresponding to the N-terminal extracellular domain of human DcR1 precursor protein
Protein A
RUO
Antibody
Polyclonal
Human
Immunohistochemistry (Paraffin)
1 mg/mL
10mM PBS with 0.2% BSA and 0.1% sodium azide; pH 7.4
O14798
CD263, DCR1, LIT, MGC149501, MGC149502, TRAILR3, TRID
Rabbit
IgG
500 μL
4° C, do not freeze
Primary
8794
Documents
Provide Content Correction

We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Cancel Submit